About
▼
Careers
Internship
MedBlog
Contact us
English (US)
▼
LOGIN
REGISTER
☰
Explore
Healthy Living
News
Health A-Z
Calculators
Articles
Drugs
Directories
Education
More
Latest Press Releases
Submit Press Releases
‹
›
Advertisement
Medindia
»
Health Press Releases A-Z
European Medicines Agency Begins Evaluation of Marketing Application for Sublingual Sufentanil 30 mcg Tablet (ARX-04) for Moderate-to-Severe Acute Pain
Tuesday, March 28, 2017
Drug News
Advertisement
CHMP Opinion Expected First Half 2018
Latest Press Release on Drug News
UT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) will direct a team of researchers to investigate a novel oral vaccine for chlamydia, the most rep...
GIBF invests $10 Million in Nectin Therapeutics to Advance Novel Pipeline of First-in-Class Immunotherapies and Antibody Drug Conjugates
Proceeds from financing to support ongoing clinical development of lead program targeting PVR as well as IND-enabling activities for multiple ADC candidates TEL AVIV, Israel , ...
Recently Published Real-World Evidence Study Shows Effectiveness of Cell-Based Quadrivalent Influenza Vaccine Over Three Seasons
A real-world evidence (RWE) study recently published in Open Forum Infectious Diseases (OFID) examined three consecutive U.S. flu seasons in the United States . The study suggests th...
Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020
TAIPEI , April 30, 2024 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP...
PANTHERx® Rare Partnering with X4 Pharmaceuticals Inc. for the Distribution of XOLREMDI™ (mavorixafor), the First FDA-Approved Therapy Indicated for Use in Patients with WHIM Syndrome
PITTSBURGH , April 29, 2024 /PRNewswire/ -- PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selec...
About Us
Editorial Team
Exclusive Interviews
In the News
Partners & Affiliates
Advertise With Us
Sitemap
हिन्दी
français
Español
中文
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our
Cookie Policy
,
Privacy Policy
, and our
Terms of Use
Ok, Got it.
Close
↑